Y2X Life Sciences Completes Option Agreement For SARS-CoV-2 Detection Technology From Washington University In St. Louis
NEW YORK & ST. LOUIS–(BUSINESS WIRE)–Y2X Life Sciences, a New York-based leader in products that disrupt the transmission of infectious disease, today announced it has entered into an option agreement…